[
  {
    "id": "1756319349153-qdtdrc",
    "title": "New GLP-1 pill for weight loss may be closer to reality as drugmaker Eli Lilly says it will file for regulatory approval | CNN",
    "date": "2025-08-27T18:29:09.152Z",
    "summary": "The latest results from a trial of a pill form popular GLP-1 medications offer enough information for the Eli Lilly to request global regulatory approval this year, the company said Tuesday.\nLilly, which makes the injectable drugs Zepbound to treat obesity and Mounjaro and Trulicity to treat diabetes, is among several companies chasing an effective pill form of such GLP-1 receptor agonists. In May, the US Food and Drug Administration accepted Novo Nordisk’s marketing application for an oral version of its weight-loss drug Wegovy, with a decision expected toward the end of the year.\nThe only semaglutide pill that’s currently available, Rybelsus, treats type 2 diabetes and comes with diet rest…",
    "sourceHost": "cnn.com",
    "sourceUrl": "https://www.cnn.com/2025/08/26/health/glp-1-pill-eli-lilly",
    "mdUrl": "https://github.com/OnLi1971/mounjaro-summaries/blob/main/summaries/2025-08-27-taopnn.md"
  },
  {
    "id": "1756319346960-iqq432",
    "title": "Eli Lilly's oral GLP-1 pill may help people with Type 2 diabetes lose 'significant' weight, study finds",
    "date": "2025-08-27T18:29:06.959Z",
    "summary": "Eli Lilly is releasing new Phase 3 trial results Tuesday.\nDrugmaker Eli Lilly says its daily oral GLP-1 pill may help people who have obesity and people with Type 2 diabetes lose approximately 23 pounds or more than 10% of their body weight on average, according to new data released Tuesday morning.\nEli Lilly said the oral GLP-1 pill has been shown to reduce hemoglobin A1C levels -- a blood test that shows average blood sugar levels over two to three months -- by an average of 1.3% to 1.8% in people with diabetes.\nThe Phase 3 trial study results were based on trial participants who took the highest dose of 36 milligrams for more than a year, or approximately 17 months.\nEli Lilly's latest dat…",
    "sourceHost": "abcnews.go.com",
    "sourceUrl": "https://abcnews.go.com/GMA/Wellness/eli-lillys-oral-glp-1-pill-people-type/story?id=124963525",
    "mdUrl": "https://github.com/OnLi1971/mounjaro-summaries/blob/main/summaries/2025-08-27-mmuhl5.md"
  },
  {
    "id": "1756317309193-hsi30j",
    "title": "Our Phase 3 ATTAIN-2 study demonstrated that an oral GLP-1 has the potential to achieve weight loss consistent with injectables in patients with both diabetes and obesity — a popul",
    "date": "2025-08-27T17:55:09.193Z",
    "summary": "Agree & Join LinkedIn\nBy clicking Continue to join or sign in, you agree to LinkedIn’s User Agreement, Privacy Policy, and Cookie Policy.\nChief Scientific Officer and President, Lilly Research Laboratories; President, Immunology at Eli Lilly and Company\nOur Phase 3 ATTAIN-2 study demonstrated that an oral GLP-1 has the potential to achieve weight loss consistent with injectables in patients with both diabetes and obesity — a population where weight loss has historically been most challenging.",
    "sourceHost": "linkedin.com",
    "sourceUrl": "https://www.linkedin.com/posts/danielskovronsky_our-phase-3-attain-2-study-demonstrated-that-activity-7366123120128081920-1Olh",
    "mdUrl": "https://github.com/OnLi1971/mounjaro-summaries/blob/main/summaries/2025-08-27-kx7gy9.md"
  },
  {
    "id": "1756317306967-7ino7j",
    "title": "Lilly's oral GLP-1, orforglipron, is successful in third Phase 3 trial, triggering global regulatory submissions this year for the treatment of obesity | Eli Lilly and Company",
    "date": "2025-08-27T17:55:06.966Z",
    "summary": "In ATTAIN-2, orforglipron met the primary and all key secondary endpoints, with compelling efficacy results and a safety profile consistent with injectable GLP-1 medicines\nParticipants with obesity or overweight and type 2 diabetes, a population with increased difficulties losing weight, lost an average of 22.9 lbs (10.5%) on the highest dose, with A1C reduced by an average of 1.8%\nINDIANAPOLIS, Aug. 26, 2025 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced positive topline results from the Phase 3 ATTAIN-2 trial, evaluating orforglipron, an investigational oral GLP-1 receptor agonist, in adults with obesity or overweight and type 2 diabetes. In the trial, all three doses of…",
    "sourceHost": "investor.lilly.com",
    "sourceUrl": "https://investor.lilly.com/news-releases/news-release-details/lillys-oral-glp-1-orforglipron-successful-third-phase-3-trial",
    "mdUrl": "https://github.com/OnLi1971/mounjaro-summaries/blob/main/summaries/2025-08-27-gtqof1.md"
  },
  {
    "title": "Vzestup celebritních endorsementů v oblasti farmacie a jejich dopady",
    "sourceUrl": "https://www.webpronews.com/serena-williams-reveals-glp-1-use-for-postpartum-weight-loss-faces-backlash/",
    "summaryUrl": "https://github.com/OnLi1971/mounjaro-summaries/blob/main/summaries/2025-08-27-1jm4mh.md",
    "date": "2025-08-27"
  },
  {
    "title": "Ecnoglutid jako nová účinná léčba diabetu 2. typu s lepší kontrolou glykémie a váhy",
    "sourceUrl": "https://www.sciencedirect.com/science/article/abs/pii/S2213858725001962",
    "summaryUrl": "https://github.com/OnLi1971/mounjaro-summaries/blob/main/summaries/2025-08-27-k6lgbl.md",
    "date": "2025-08-27"
  },
  {
    "title": "Serena Williams jako ambasadorka GLP-1 léčby u Ro",
    "sourceUrl": "https://femtechinsider.com/serena-williams-ro-and-the-uneasy-promise-of-celebrity-backed-glp-1-campaigns/",
    "summaryUrl": "https://github.com/OnLi1971/mounjaro-summaries/blob/main/summaries/2025-08-27-4vvirq.md",
    "date": "2025-08-27"
  },
  {
    "title": "Pozitivní účinky GLP-1 léků na zdraví a kvalitu života pacientů",
    "sourceUrl": "https://www.aol.com/lifestyle/too-young-waking-pain-glp-090033409.html",
    "summaryUrl": "https://github.com/OnLi1971/mounjaro-summaries/blob/main/summaries/2025-08-27-ik45qo.md",
    "date": "2025-08-27"
  },
  {
    "title": "GLP-1 receptor agonisté v léčbě Parkinsonovy nemoci: přehled a metaanalýza",
    "sourceUrl": "https://dmsjournal.biomedcentral.com/articles/10.1186/s13098-025-01888-1",
    "summaryUrl": "https://github.com/OnLi1971/mounjaro-summaries/blob/main/summaries/2025-08-27-th451u.md",
    "date": "2025-08-27"
  },
  {
    "title": "Odkaz: thehill.com",
    "sourceUrl": "https://thehill.com/policy/healthcare/5467385-ozempic-teeth-new-side-effect-weightloss-drugs/",
    "summaryUrl": "https://github.com/OnLi1971/mounjaro-summaries/blob/main/summaries/2025-08-27-vtqpf3.md",
    "date": "2025-08-27"
  },
  {
    "title": "Studie zjistila snížení rizika rakoviny u uživatelů léků GLP-1 na hubnutí",
    "sourceUrl": "https://oncodaily.com/science/glp-1-receptor-agonists-353999",
    "summaryUrl": "https://github.com/OnLi1971/mounjaro-summaries/blob/main/summaries/2025-08-27-r9w6ki.md",
    "date": "2025-08-27"
  },
  {
    "title": "Metabolický syndrom a riziko rychlého jedení pro zdraví",
    "sourceUrl": "https://nypost.com/2025/08/22/health/common-mistake-can-mess-with-bodys-natural-ozempic-hormones-up-diabetes-risk/",
    "summaryUrl": "https://github.com/OnLi1971/mounjaro-summaries/blob/main/summaries/2025-08-27-e2uech.md",
    "date": "2025-08-27"
  },
  {
    "title": "Odkaz: wane.com",
    "sourceUrl": "https://www.wane.com/news/ozempic-teeth-dentists-warn-of-new-glp-1-side-effect/",
    "summaryUrl": "https://github.com/OnLi1971/mounjaro-summaries/blob/main/summaries/2025-08-27-6awch7.md",
    "date": "2025-08-27"
  },
  {
    "title": "Eli Lilly zvyšuje cenu léku Mounjaro v UK až o 170 procent",
    "sourceUrl": "https://www.lbc.co.uk/article/lib-dems-watchdog-mounjaro-sales-suspended-5HjdBXR_2/",
    "summaryUrl": "https://github.com/OnLi1971/mounjaro-summaries/blob/main/summaries/2025-08-27-64q6jv.md",
    "date": "2025-08-27"
  },
  {
    "title": "Clinton Hall nabízí mini jídla pro hosty užívající Ozempic a podobné léky",
    "sourceUrl": "https://tribecacitizen.com/2025/08/27/in-the-news-7/",
    "summaryUrl": "https://github.com/OnLi1971/mounjaro-summaries/blob/main/summaries/2025-08-27-37tp8g.md",
    "date": "2025-08-27"
  },
  {
    "title": "Nemocniční lékárenství a farmaceutická péče v ČR",
    "sourceUrl": "https://www.chemistanddruggist.co.uk/news/clinical/online-pharmacies-see-mounjaro-stock-shortages-amid-price-hike-DCD7L3VLRNHOJDBA5ITYD22X4I/",
    "summaryUrl": "https://github.com/OnLi1971/mounjaro-summaries/blob/main/summaries/2025-08-27-pq62wx.md",
    "date": "2025-08-27"
  },
  {
    "title": "Eli Lilly představuje orální pilulku na hubnutí orforglipron",
    "sourceUrl": "https://www.cnbc.com/2025/08/24/eli-lilly-oral-obesity-pill-novo-nordisk.html",
    "summaryUrl": "https://github.com/OnLi1971/mounjaro-summaries/blob/main/summaries/2025-08-27-0vz7y0.md",
    "date": "2025-08-27"
  },
  {
    "title": "Mounjaro (Tirzepatid) zdraží od září 2025 v UK, NHS ceny se přizpůsobí",
    "sourceUrl": "https://www.thepharmacist.co.uk/clinical/nutrition-and-gastroenterology/mounjaro-nhs-reimbursement-agreement-in-place-for-september/",
    "summaryUrl": "https://github.com/OnLi1971/mounjaro-summaries/blob/main/summaries/2025-08-27-81onf5.md",
    "date": "2025-08-27"
  },
  {
    "title": "Rychlý růst spotřeby a nákladů na léky GLP-1 v USA",
    "sourceUrl": "https://www.ama-assn.org/public-health/prevention-wellness/spending-glp-1s-has-grown-dramatically-here-are-details",
    "summaryUrl": "https://github.com/OnLi1971/mounjaro-summaries/blob/main/summaries/2025-08-27-8t5oi0.md",
    "date": "2025-08-27"
  },
  {
    "title": "Odkaz: business-standard.com",
    "sourceUrl": "https://www.business-standard.com/health/serena-williams-glp1-drugs-weight-loss-ozempic-zepbound-fitness-125082500636_1.html",
    "summaryUrl": "https://github.com/OnLi1971/mounjaro-summaries/blob/main/summaries/2025-08-27-vorwlw.md",
    "date": "2025-08-27"
  },
  {
    "title": "Jak fungují injekce GLP-1 na hubnutí a jejich účinky",
    "sourceUrl": "https://gulfnews.com/lifestyle/health-fitness/inside-serena-williams-14kg-weight-loss-how-glp-1-injections-work-and-5-side-effects-to-know-1.500244395",
    "summaryUrl": "https://github.com/OnLi1971/mounjaro-summaries/blob/main/summaries/2025-08-27-d5n0l0.md",
    "date": "2025-08-27"
  },
  {
    "title": "New study suggests a link between GLP-1s and lower cancer risk",
    "sourceUrl": "https://www.goodmorningamerica.com/wellness/video/new-study-suggests-link-glp-1sand-lower-cancer-124929714",
    "summaryUrl": "https://github.com/OnLi1971/mounjaro-summaries/blob/main/summaries/2025-08-27-86y9nr.md",
    "date": "2025-08-27"
  },
  {
    "title": "MSN",
    "sourceUrl": "http://www.msn.com/en-us/sports/nba/serena-williams-reveals-the-real-reason-why-she-used-glp-1-medication-to-lose-weight/ar-AA1L2ATN?apiversion=v2&noservercache=1&domshim=1&renderwebcomponents=1&wcseo=1&batchservertelemetry=1&noservertelemetry=1",
    "summaryUrl": "https://github.com/OnLi1971/mounjaro-summaries/blob/main/summaries/2025-08-27-5egxn8.md",
    "date": "2025-08-27"
  },
  {
    "title": "Shrnutí článku",
    "sourceUrl": "https://firstwordpharma.com/story/5991600",
    "summaryUrl": "https://github.com/OnLi1971/mounjaro-summaries/blob/main/summaries/2025-08-27-iun77c.md",
    "date": "2025-08-27"
  },
  {
    "title": "Serena Williams jako tvář léků na hubnutí GLP-1 mění vnímání",
    "sourceUrl": "https://www.the-independent.com/voices/serena-williams-glp1-weight-loss-drugs-ro-alexis-ohanian-b2813255.html",
    "summaryUrl": "https://github.com/OnLi1971/mounjaro-summaries/blob/main/summaries/2025-08-27-agjh2h.md",
    "date": "2025-08-27"
  },
  {
    "title": "Dominance GLP-1 léků v televizní reklamě a trendy v roce 2025",
    "sourceUrl": "https://www.emarketer.com/content/glp-1-drugs-dominate-prescription-tv-ad-spend",
    "summaryUrl": "https://github.com/OnLi1971/mounjaro-summaries/blob/main/summaries/2025-08-27-r5z79l.md",
    "date": "2025-08-27"
  },
  {
    "title": "GLP-1 léky pomáhají s hubnutím i kontrolou cukru v krvi",
    "sourceUrl": "https://www.hindustantimes.com/lifestyle/health/serena-williams-lost-14-kg-using-glp-1-drug-8-things-to-know-about-the-weight-loss-medication-101756046354195.html",
    "summaryUrl": "https://github.com/OnLi1971/mounjaro-summaries/blob/main/summaries/2025-08-27-v22nsm.md",
    "date": "2025-08-27"
  },
  {
    "title": "Ozempic a Wegovy mohou způsobovat poškození zubů a problémy v ústech",
    "sourceUrl": "https://ca.news.yahoo.com/ozempic-teeth-dentists-warn-glp-184445013.html",
    "summaryUrl": "https://github.com/OnLi1971/mounjaro-summaries/blob/main/summaries/2025-08-27-q3huxg.md",
    "date": "2025-08-27"
  },
  {
    "title": "Serena Williams a kontroverze kolem jejího hubnutí s GLP-1 lékem",
    "sourceUrl": "https://www.npr.org/2025/08/25/nx-s1-5511375/the-controversy-around-serena-williams-weight-loss-is-more-nuanced-than-you-may-think",
    "summaryUrl": "https://github.com/OnLi1971/mounjaro-summaries/blob/main/summaries/2025-08-27-8a2ogr.md",
    "date": "2025-08-27"
  },
  {
    "title": "Protizánětlivé účinky agonistů GLP-1 a jejich vliv na metabolická onemocnění",
    "sourceUrl": "https://www.cureus.com/articles/403226-glucagon-like-peptide-1-glp-1-receptor-agonist-use-and-inflammatory-markers-among-us-adults-a-national-health-and-nutrition-examination-survey-nhanes-based-analysis?score_article=true",
    "summaryUrl": "https://github.com/OnLi1971/mounjaro-summaries/blob/main/summaries/2025-08-27-ptory3.md",
    "date": "2025-08-27"
  },
  {
    "title": "Ecnoglutid jako nová naděje v léčbě diabetu 2. typu a hubnutí",
    "sourceUrl": "https://www.sciencealert.com/new-weight-loss-drug-outperformed-existing-treatment-in-clinical-trial",
    "summaryUrl": "https://github.com/OnLi1971/mounjaro-summaries/blob/main/summaries/2025-08-27-9aoxxz.md",
    "date": "2025-08-27"
  },
  {
    "title": "Broker Innovation Lab oslavuje inovace v oblasti benefitů",
    "sourceUrl": "https://www.benefitspro.com/2025/08/25/glp-1-coverage-a-roadmap-for-balancing-cost-and-care/",
    "summaryUrl": "https://github.com/OnLi1971/mounjaro-summaries/blob/main/summaries/2025-08-27-24cqjs.md",
    "date": "2025-08-27"
  },
  {
    "title": "Serena Williams a její váhová proměna díky léku GLP-1",
    "sourceUrl": "https://www.yahoo.com/entertainment/celebrity/articles/actress-slams-serena-williams-weight-014521361.html",
    "summaryUrl": "https://github.com/OnLi1971/mounjaro-summaries/blob/main/summaries/2025-08-27-vdsp51.md",
    "date": "2025-08-27"
  },
  {
    "title": "Léky GLP-1 mění zdravotnictví i ekonomiku s obrovským potenciálem",
    "sourceUrl": "https://www.cnbc.com/2025/08/26/how-glp-1s-wegovy-zepbound-are-reshaping-the-economy.html",
    "summaryUrl": "https://github.com/OnLi1971/mounjaro-summaries/blob/main/summaries/2025-08-27-e6jr0i.md",
    "date": "2025-08-27"
  },
  {
    "title": "NYC restaurace nabízí speciální jídla pro uživatele GLP-1 léků na hubnutí",
    "sourceUrl": "https://www.foxnews.com/food-drink/ozempic-users-can-barely-finish-third-restaurant-orders",
    "summaryUrl": "https://github.com/OnLi1971/mounjaro-summaries/blob/main/summaries/2025-08-27-tgf2yy.md",
    "date": "2025-08-27"
  },
  {
    "title": "Broker Innovation Lab oslavuje inovace v oblasti benefitů a pojištění",
    "sourceUrl": "https://www.benefitspro.com/2025/08/25/glp-1s-a-weight-loss-staple-in-american-homes/",
    "summaryUrl": "https://github.com/OnLi1971/mounjaro-summaries/blob/main/summaries/2025-08-27-2n0scu.md",
    "date": "2025-08-27"
  },
  {
    "title": "Výzvy v dávkování a účinnosti GLP-1 léků u pacientů s obezitou",
    "sourceUrl": "https://www.drugtopics.com/view/glp-1-titration-remains-persistent-challenge-among-patients-with-obesity",
    "summaryUrl": "https://github.com/OnLi1971/mounjaro-summaries/blob/main/summaries/2025-08-27-dulvey.md",
    "date": "2025-08-27"
  },
  {
    "title": "GLP-1 léky snižují riziko některých druhů rakoviny spojených s obezitou",
    "sourceUrl": "https://www.everydayhealth.com/cancer/weight-loss-drugs-may-reduce-the-risk-of-some-cancers/",
    "summaryUrl": "https://github.com/OnLi1971/mounjaro-summaries/blob/main/summaries/2025-08-27-8p6mjl.md",
    "date": "2025-08-27"
  },
  {
    "title": "Noom Microdose GLP-1 program pro hubené s nižšími dávkami a vedlejšími účinky",
    "sourceUrl": "https://www.medicalnewstoday.com/articles/glp-1-microdosing-for-weight-loss-experts-weigh-the-pros-and-cons",
    "summaryUrl": "https://github.com/OnLi1971/mounjaro-summaries/blob/main/summaries/2025-08-27-lpij4d.md",
    "date": "2025-08-27"
  },
  {
    "title": "Odkaz: m.facebook.com",
    "sourceUrl": "https://m.facebook.com/JuliaSamuelMBE/videos/the-truth-behind-body-image-and-quick-fixes-ozempic-mounjaro-they-promise-the-bo/1057939986368656/",
    "summaryUrl": "https://github.com/OnLi1971/mounjaro-summaries/blob/main/summaries/2025-08-27-mjalbs.md",
    "date": "2025-08-27"
  },
  {
    "title": "Přístup k GLP-1 receptorovým agonistům u dospívajících a mladých dospělých",
    "sourceUrl": "https://www.gastroenterologyadvisor.com/news/study-ids-barriers-to-glp-1-receptor-agonist-use-in-adolescents-young-adults/",
    "summaryUrl": "https://github.com/OnLi1971/mounjaro-summaries/blob/main/summaries/2025-08-27-xxh4mg.md",
    "date": "2025-08-27"
  },
  {
    "title": "Cena léku Mounjaro v UK vzroste až o 170 % od září 2025",
    "sourceUrl": "https://www.theguardian.com/business/2025/aug/14/eli-lilly-uk-price-weight-loss-jab-mounjaro-trump",
    "summaryUrl": "https://github.com/OnLi1971/mounjaro-summaries/blob/main/summaries/2025-08-27-hvrwpa.md",
    "date": "2025-08-27"
  },
  {
    "title": "Nebezpečí a rizika nelegálních GLP-1 léků na hubnutí",
    "sourceUrl": "https://www.everydayhealth.com/weight-management/fda-raises-safety-concerns-with-compounded-glp-1-weight-loss-drugs/",
    "summaryUrl": "https://github.com/OnLi1971/mounjaro-summaries/blob/main/summaries/2025-08-27-9mpg1j.md",
    "date": "2025-08-27"
  },
  {
    "title": "Odkaz: finance.yahoo.com",
    "sourceUrl": "https://finance.yahoo.com/news/eli-lilly-raising-glp-1-prices-abroad-raises-more-questions-about-us-pricing-bofa-analyst-191601993.html",
    "summaryUrl": "https://github.com/OnLi1971/mounjaro-summaries/blob/main/summaries/2025-08-27-ci8iet.md",
    "date": "2025-08-27"
  },
  {
    "title": "MSN",
    "sourceUrl": "https://www.msn.com/en-us/health/other/staggeringly-high-discontinuation-rates-for-glp-1-drugs-like-ozempic-or-wegovy/ar-AA1uj3OS?apiversion=v2",
    "summaryUrl": "https://github.com/OnLi1971/mounjaro-summaries/blob/main/summaries/2025-08-27-d329xl.md",
    "date": "2025-08-27"
  },
  {
    "title": "GLP-1 agonisté: účinky, rozdíly a vedlejší účinky nových léků na diabetes a obezitu",
    "sourceUrl": "http://uknow.uky.edu/uk-healthcare/new-generation-weight-loss-drugs-pros-and-cons-glp-1s",
    "summaryUrl": "https://github.com/OnLi1971/mounjaro-summaries/blob/main/summaries/2025-08-27-ge9ys5.md",
    "date": "2025-08-27"
  },
  {
    "title": "Odkaz: qz.com",
    "sourceUrl": "https://qz.com/novo-nordisk-stock-pops-discount-ozempic-cash",
    "summaryUrl": "https://github.com/OnLi1971/mounjaro-summaries/blob/main/summaries/2025-08-27-zimh1v.md",
    "date": "2025-08-27"
  },
  {
    "title": "Jak posilovat svaly při užívání léků GLP-1 na hubnutí",
    "sourceUrl": "https://www.cnn.com/2025/08/18/health/glp1-muscle-loss-strength-training-wellness",
    "summaryUrl": "https://github.com/OnLi1971/mounjaro-summaries/blob/main/summaries/2025-08-27-9ayj6c.md",
    "date": "2025-08-27"
  },
  {
    "title": "Semaglutid a tirzepatid: rozdíly, dostupnost a bezpečnost léků na hubnutí",
    "sourceUrl": "https://www.nebraskamed.com/health/healthy-lifestyle/bariatrics-weight-loss/what-you-need-to-know-about-the-compounded-glp-1",
    "summaryUrl": "https://github.com/OnLi1971/mounjaro-summaries/blob/main/summaries/2025-08-27-zxlqd0.md",
    "date": "2025-08-27"
  },
  {
    "title": "Používání GLP-1 RA injekcí u dospělých s diabetem v roce 2024",
    "sourceUrl": "https://www.rheumatologyadvisor.com/news/26-5-percent-of-adults-with-diabetes-used-glp-1-ra-injectables-in-2024/",
    "summaryUrl": "https://github.com/OnLi1971/mounjaro-summaries/blob/main/summaries/2025-08-27-gl9tez.md",
    "date": "2025-08-27"
  },
  {
    "title": "Serena Williams otevřeně o užívání GLP-1 léků na hubnutí",
    "sourceUrl": "https://www.today.com/health/womens-health/serena-williams-glp-1-weight-loss-rcna226141",
    "summaryUrl": "https://github.com/OnLi1971/mounjaro-summaries/blob/main/summaries/2025-08-27-uw3q86.md",
    "date": "2025-08-27"
  },
  {
    "title": "Serena Williams otevřeně o váze a užívání léků na hubnutí po porodu",
    "sourceUrl": "https://www.womenshealthmag.com/uk/fitness/fat-loss/a65862142/serena-williams-weight-loss-glp1-ro/",
    "summaryUrl": "https://github.com/OnLi1971/mounjaro-summaries/blob/main/summaries/2025-08-27-h6qnfm.md",
    "date": "2025-08-27"
  },
  {
    "title": "Prodej léku Wegovy v UK vzrostl o 2000 % díky zdražení Mounjaro",
    "sourceUrl": "https://www.ibtimes.co.uk/uk-sales-wegovy-skyrocket-2000-dieters-dump-mounjaro-after-170-price-hike-1742037",
    "summaryUrl": "https://github.com/OnLi1971/mounjaro-summaries/blob/main/summaries/2025-08-27-jemnx9.md",
    "date": "2025-08-27"
  },
  {
    "title": "PressReader.com - Digital Newspaper & Magazine Subscriptions",
    "sourceUrl": "https://www.pressreader.com/usa/the-washington-post-sunday-598/20250824/281904484282452",
    "summaryUrl": "https://github.com/OnLi1971/mounjaro-summaries/blob/main/summaries/2025-08-27-wo0hiu.md",
    "date": "2025-08-27"
  },
  {
    "title": "Terns Pharmaceuticals ukončuje vývoj v oblasti obezity a zaměřuje se na onkologii",
    "sourceUrl": "https://www.biospace.com/drug-development/weight-loss-wasteland-5-obesity-assets-that-failed",
    "summaryUrl": "https://github.com/OnLi1971/mounjaro-summaries/blob/main/summaries/2025-08-27-q50rjj.md",
    "date": "2025-08-27"
  },
  {
    "title": "Odkaz: thelancet.com",
    "sourceUrl": "https://www.thelancet.com/journals/landia/article/PIIS2213-8587(25)00197-4/fulltext?rss=yes",
    "summaryUrl": "https://github.com/OnLi1971/mounjaro-summaries/blob/main/summaries/2025-08-27-cusq8v.md",
    "date": "2025-08-27"
  },
  {
    "title": "Menopauzální hormonální terapie zlepšuje účinnost hubnutí s tirzepatidem",
    "sourceUrl": "https://www.empr.com/news/endo-superior-weight-loss-seen-with-tirzepatide-and-menopausal-hormone-therapy-use/",
    "summaryUrl": "https://github.com/OnLi1971/mounjaro-summaries/blob/main/summaries/2025-08-27-j09m9f.md",
    "date": "2025-08-27"
  },
  {
    "title": "Odkaz: pharmacytimes.com",
    "sourceUrl": "https://www.pharmacytimes.com/view/obesity-messaging-glp-1-agonists-and-the-pharmacist-s-ethical-imperative-navigating-a-shifting-landscape",
    "summaryUrl": "https://github.com/OnLi1971/mounjaro-summaries/blob/main/summaries/2025-08-27-2o5jfs.md",
    "date": "2025-08-27"
  },
  {
    "title": "Odkaz: everydayhealth.com",
    "sourceUrl": "https://www.everydayhealth.com/obesity/glp-1-pill-helps-people-with-obesity-lose-thirty-pounds-in-new-trial/",
    "summaryUrl": "https://www.everydayhealth.com/obesity/glp-1-pill-helps-people-with-obesity-lose-thirty-pounds-in-new-trial/",
    "date": "2025-08-26"
  },
  {
    "title": "Odkaz: chiefhealthcareexecutive.com",
    "sourceUrl": "https://www.chiefhealthcareexecutive.com/view/glp-1-drugs-and-those-who-take-them-che-explainer",
    "summaryUrl": "https://www.chiefhealthcareexecutive.com/view/glp-1-drugs-and-those-who-take-them-che-explainer",
    "date": "2025-08-26"
  },
  {
    "title": "Odkaz: rollingstone.com",
    "sourceUrl": "https://www.rollingstone.com/culture/culture-features/glp1-patches-influencers-ozempic-1235403902/",
    "summaryUrl": "https://www.rollingstone.com/culture/culture-features/glp1-patches-influencers-ozempic-1235403902/",
    "date": "2025-08-26"
  },
  {
    "title": "Odkaz: ift.org",
    "sourceUrl": "https://www.ift.org/news-and-publications/blog/2025/smarter-nutrition-in-the-age-of-glp-1s",
    "summaryUrl": "https://www.ift.org/news-and-publications/blog/2025/smarter-nutrition-in-the-age-of-glp-1s",
    "date": "2025-08-26"
  },
  {
    "title": "Odkaz: abdpost.com",
    "sourceUrl": "https://www.abdpost.com/travis-barkers-ex-shanna-moakler-flaunts-mounjaro-weight-loss/399095",
    "summaryUrl": "https://www.abdpost.com/travis-barkers-ex-shanna-moakler-flaunts-mounjaro-weight-loss/399095",
    "date": "2025-08-26"
  },
  {
    "title": "Odkaz: abcnews.go.com",
    "sourceUrl": "https://abcnews.go.com/GMA/Wellness/daily-oral-glp-1-pill-effective-weekly-shots/story?id=124440685",
    "summaryUrl": "https://abcnews.go.com/GMA/Wellness/daily-oral-glp-1-pill-effective-weekly-shots/story?id=124440685",
    "date": "2025-08-26"
  },
  {
    "title": "Odkaz: cnn.com",
    "sourceUrl": "https://www.cnn.com/2025/08/07/health/lilly-glp1-pill-weight-loss",
    "summaryUrl": "https://www.cnn.com/2025/08/07/health/lilly-glp1-pill-weight-loss",
    "date": "2025-08-26"
  },
  {
    "title": "Odkaz: fiercebiotech.com",
    "sourceUrl": "https://www.fiercebiotech.com/biotech/pfizers-embattled-obesity-program-loses-another-glp-1-drug",
    "summaryUrl": "https://www.fiercebiotech.com/biotech/pfizers-embattled-obesity-program-loses-another-glp-1-drug",
    "date": "2025-08-26"
  },
  {
    "title": "Odkaz: medicine.yale.edu",
    "sourceUrl": "https://medicine.yale.edu/news-article/new-research-letter-examines-glp-1-access-for-adolescents-and-young-adults/",
    "summaryUrl": "https://medicine.yale.edu/news-article/new-research-letter-examines-glp-1-access-for-adolescents-and-young-adults/",
    "date": "2025-08-26"
  },
  {
    "title": "Odkaz: bbc.com",
    "sourceUrl": "https://www.bbc.com/news/articles/cwy3jg20j1ro",
    "summaryUrl": "https://www.bbc.com/news/articles/cwy3jg20j1ro",
    "date": "2025-08-26"
  },
  {
    "title": "Odkaz: medicaldialogues.in",
    "sourceUrl": "https://medicaldialogues.in/amp/cardiology-ctvs/news/cardiac-safety-data-of-tirzepatide-released-tirzepatide-offers-additional-cardiac-benefits-over-dulaglutide-in-surpass-cvot-trial-152904",
    "summaryUrl": "https://medicaldialogues.in/amp/cardiology-ctvs/news/cardiac-safety-data-of-tirzepatide-released-tirzepatide-offers-additional-cardiac-benefits-over-dulaglutide-in-surpass-cvot-trial-152904",
    "date": "2025-08-26"
  },
  {
    "title": "Odkaz: nutritioninsight.com",
    "sourceUrl": "https://www.nutritioninsight.com/news/gut-bacteria-glp-1-fat-loss-blood-sugar",
    "summaryUrl": "https://www.nutritioninsight.com/news/gut-bacteria-glp-1-fat-loss-blood-sugar",
    "date": "2025-08-26"
  },
  {
    "title": "Odkaz: thehill.com",
    "sourceUrl": "https://thehill.com/policy/healthcare/5433642-americans-awareness-weight-loss-drugs-ozempic-wegovy-survey/",
    "summaryUrl": "https://thehill.com/policy/healthcare/5433642-americans-awareness-weight-loss-drugs-ozempic-wegovy-survey/",
    "date": "2025-08-26"
  },
  {
    "title": "Odkaz: hsph.harvard.edu",
    "sourceUrl": "https://hsph.harvard.edu/news/ozempic-wegovy-inspire-wave-of-glp-1-supplements-but-are-they-safe-or-effective/",
    "summaryUrl": "https://hsph.harvard.edu/news/ozempic-wegovy-inspire-wave-of-glp-1-supplements-but-are-they-safe-or-effective/",
    "date": "2025-08-26"
  },
  {
    "title": "Odkaz: statnews.com",
    "sourceUrl": "https://www.statnews.com/2025/08/01/glp-1s-weight-loss-medication-ozempic-access-cost-medicare-medicaid/",
    "summaryUrl": "https://www.statnews.com/2025/08/01/glp-1s-weight-loss-medication-ozempic-access-cost-medicare-medicaid/",
    "date": "2025-08-26"
  },
  {
    "title": "Odkaz: investor.lilly.com",
    "sourceUrl": "https://investor.lilly.com/news-releases/news-release-details/lillys-mounjaro-tirzepatide-gipglp-1-dual-agonist-demonstrated",
    "summaryUrl": "https://investor.lilly.com/news-releases/news-release-details/lillys-mounjaro-tirzepatide-gipglp-1-dual-agonist-demonstrated",
    "date": "2025-08-26"
  },
  {
    "title": "Odkaz: thebody.com",
    "sourceUrl": "https://www.thebody.com/hiv/glp1-inhibitors-hiv-what-you-need-to-know",
    "summaryUrl": "https://www.thebody.com/hiv/glp1-inhibitors-hiv-what-you-need-to-know",
    "date": "2025-08-26"
  },
  {
    "title": "Odkaz: investors.hims.com",
    "sourceUrl": "https://investors.hims.com/news/news-details/2025/Hims--Hers-Data-Shows-Personalized-GLP-1-Plans-Drive-Real-Weight-Loss-Few-Side-Effects-and-Strong-Adherence-to-Care/default.aspx",
    "summaryUrl": "https://investors.hims.com/news/news-details/2025/Hims--Hers-Data-Shows-Personalized-GLP-1-Plans-Drive-Real-Weight-Loss-Few-Side-Effects-and-Strong-Adherence-to-Care/default.aspx",
    "date": "2025-08-26"
  },
  {
    "title": "Odkaz: thecardiologyadvisor.com",
    "sourceUrl": "https://www.thecardiologyadvisor.com/news/tirzepatide-slows-kidney-decline-in-prediabetes-with-overweight-obesity/",
    "summaryUrl": "https://www.thecardiologyadvisor.com/news/tirzepatide-slows-kidney-decline-in-prediabetes-with-overweight-obesity/",
    "date": "2025-08-26"
  },
  {
    "title": "Odkaz: renalandurologynews.com",
    "sourceUrl": "https://www.renalandurologynews.com/news/cancer-diabetes-t2dm-glp-1ra-improved-survival-patients/",
    "summaryUrl": "https://www.renalandurologynews.com/news/cancer-diabetes-t2dm-glp-1ra-improved-survival-patients/",
    "date": "2025-08-26"
  },
  {
    "title": "Odkaz: news.cuanschutz.edu",
    "sourceUrl": "https://news.cuanschutz.edu/cancer-center/glp-1-drugs-thyroid-cancer",
    "summaryUrl": "https://news.cuanschutz.edu/cancer-center/glp-1-drugs-thyroid-cancer",
    "date": "2025-08-26"
  },
  {
    "title": "Odkaz: finance.yahoo.com",
    "sourceUrl": "https://finance.yahoo.com/news/could-glp-1-drugs-potentially-131600282.html",
    "summaryUrl": "https://finance.yahoo.com/news/could-glp-1-drugs-potentially-131600282.html",
    "date": "2025-08-26"
  },
  {
    "title": "Odkaz: livemint.com",
    "sourceUrl": "https://www.livemint.com/opinion/online-views/ozempic-mounjaro-semaglutide-tirzepatide-appetite-suppression-weight-loss-culture-food-addiction-soylent-exercise-health-11753364865668.html",
    "summaryUrl": "https://www.livemint.com/opinion/online-views/ozempic-mounjaro-semaglutide-tirzepatide-appetite-suppression-weight-loss-culture-food-addiction-soylent-exercise-health-11753364865668.html",
    "date": "2025-08-26"
  },
  {
    "title": "Odkaz: renalandurologynews.com",
    "sourceUrl": "https://www.renalandurologynews.com/news/glp-1-receptor-agonists-may-improve-outcomes-in-idiopathic-intracranial-hypertension/",
    "summaryUrl": "https://www.renalandurologynews.com/news/glp-1-receptor-agonists-may-improve-outcomes-in-idiopathic-intracranial-hypertension/",
    "date": "2025-08-26"
  },
  {
    "title": "Odkaz: reddit.com",
    "sourceUrl": "https://www.reddit.com/r/Zepbound/comments/1m8r1cv/zepbound_vs_mounjaro/",
    "summaryUrl": "https://www.reddit.com/r/Zepbound/comments/1m8r1cv/zepbound_vs_mounjaro/",
    "date": "2025-08-26"
  },
  {
    "title": "Odkaz: mercer.com",
    "sourceUrl": "https://www.mercer.com/en-us/insights/us-health-news/glp-1-considerations-for-2026-your-questions-answered/",
    "summaryUrl": "https://www.mercer.com/en-us/insights/us-health-news/glp-1-considerations-for-2026-your-questions-answered/",
    "date": "2025-08-26"
  },
  {
    "title": "Odkaz: news-medical.net",
    "sourceUrl": "https://www.news-medical.net/news/20250723/What-happens-to-your-weight-after-quitting-GLP-1-anti-obesity-drugs.aspx",
    "summaryUrl": "https://www.news-medical.net/news/20250723/What-happens-to-your-weight-after-quitting-GLP-1-anti-obesity-drugs.aspx",
    "date": "2025-08-26"
  },
  {
    "title": "Odkaz: gastroenterologyadvisor.com",
    "sourceUrl": "https://www.gastroenterologyadvisor.com/news/glp-1-receptor-agonist-use-in-t2d-linked-to-increased-risk-for-gerd-gerd-complications/",
    "summaryUrl": "https://www.gastroenterologyadvisor.com/news/glp-1-receptor-agonist-use-in-t2d-linked-to-increased-risk-for-gerd-gerd-complications/",
    "date": "2025-08-26"
  },
  {
    "title": "Odkaz: newsroom.uvahealth.com",
    "sourceUrl": "https://newsroom.uvahealth.com/2025/07/21/glp-1-drugs-fail-to-provide-key-weight-loss-benefit/",
    "summaryUrl": "https://newsroom.uvahealth.com/2025/07/21/glp-1-drugs-fail-to-provide-key-weight-loss-benefit/",
    "date": "2025-08-26"
  },
  {
    "title": "Odkaz: cureus.com",
    "sourceUrl": "https://www.cureus.com/articles/390268-effects-of-tirzepatide-on-low-density-lipoprotein-cholesterol-levels-in-adults-a-systematic-review",
    "summaryUrl": "https://www.cureus.com/articles/390268-effects-of-tirzepatide-on-low-density-lipoprotein-cholesterol-levels-in-adults-a-systematic-review",
    "date": "2025-08-26"
  },
  {
    "title": "Odkaz: cnbc.com",
    "sourceUrl": "https://www.cnbc.com/2025/07/20/weight-loss-drugs-could-help-treat-pcos.html",
    "summaryUrl": "https://www.cnbc.com/2025/07/20/weight-loss-drugs-could-help-treat-pcos.html",
    "date": "2025-08-26"
  },
  {
    "title": "Odkaz: cureus.com",
    "sourceUrl": "https://www.cureus.com/articles/380767-weight-loss-that-lasts-reviewing-the-long-term-impact-of-glp-1-receptor-agonists",
    "summaryUrl": "https://www.cureus.com/articles/380767-weight-loss-that-lasts-reviewing-the-long-term-impact-of-glp-1-receptor-agonists",
    "date": "2025-08-26"
  },
  {
    "title": "Odkaz: rheumatologyadvisor.com",
    "sourceUrl": "https://www.rheumatologyadvisor.com/news/certain-factors-may-predict-weight-fluctuations-after-glp-1-receptor-agonist-treatment/",
    "summaryUrl": "https://www.rheumatologyadvisor.com/news/certain-factors-may-predict-weight-fluctuations-after-glp-1-receptor-agonist-treatment/",
    "date": "2025-08-26"
  },
  {
    "title": "nejmJW_1L_RGB-b",
    "sourceUrl": "https://www.jwatch.org/na58926/2025/07/15/new-variations-glp-1-receptor-agonists-are-coming",
    "summaryUrl": "https://www.jwatch.org/na58926/2025/07/15/new-variations-glp-1-receptor-agonists-are-coming",
    "date": "2025-08-26"
  },
  {
    "title": "Odkaz: dailymail.co.uk",
    "sourceUrl": "https://www.dailymail.co.uk/health/article-14910243/Scientists-discover-new-link-Mounjaro-BREAST-cancer.html",
    "summaryUrl": "https://www.dailymail.co.uk/health/article-14910243/Scientists-discover-new-link-Mounjaro-BREAST-cancer.html",
    "date": "2025-08-26"
  }
]